Overview

Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit

Status:
Recruiting
Trial end date:
2023-12-20
Target enrollment:
Participant gender:
Summary
Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit
Phase:
Phase 1
Details
Lead Sponsor:
Minia University
Treatments:
Dexmedetomidine
Midazolam